Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

STADA Arzneimittel

STADA Arzneimittel
1895 FOUNDED
PUBLIC STATUS
10K-15K EMPLOYEES
SAZ STOCK SYMBOL
31 INVESTMENTS
$96.68 SHARE PRICE (As of Thursday Closing)
Description

Stada Arzneimittel is a specialty and generic drug manufacturing company. The vast majority of the company's sales are derived from its generic drug products, followed by its branded products. Most of the company's generic sales take place in Germany, followed by Italy and Spain. Germany also leads the branded products segment, followed by the United Kingdom and Russia. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Website
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Distributors/Wholesale
Stock Exchange
HAM
Primary Office
  • Stadastraße 2-18
  • 61118 Bad Vilbel
  • Germany

+49 06101 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore STADA Arzneimittel’s full profile, request a free trial.

STADA Arzneimittel Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$90.88 - $98.43 $6.02B $96.92 $5.12 831.07 62.3M

STADA Arzneimittel Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 7,417,842 7,192,852 7,799,176 4,581,455
Revenue 2,802,384 2,750,527 2,609,566 2,366,289
EBITDA 528,230 554,435 358,205 326,074
Net Income 319,345 362,194 96,224 95,022
Total Assets 4,177,050 4,072,439 3,844,478 3,618,321
Total Debt 1,465,466 1,786,239 1,579,002 1,566,495
Public Fundamental Data provided by Morningstar, Inc. disclaimer

STADA Arzneimittel Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore STADA Arzneimittel‘s full profile, request access.

Request full access to PitchBook

STADA Arzneimittel Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Catalent Formerly PE-Backed Somerset, NJ 00000 00.000 000000 - 000 00.000
000000 00000 Corporation Mumbai, India 0000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
To view this company’s complete list of competitors, request access »

STADA Arzneimittel Investments & Acquisitions (31)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000000 (0 14-Dec-2019 000000000 00000 00 Buildings and Property 00000 00000000000
00000000 (0000000) 02-Dec-2019 000000000000000000 Drug Discovery 00000 00000000000
000000000 (0000000 02-Dec-2019 000000000000000000 Drug Discovery 00000 00000000000
000000 00000000000 05-Nov-2019 0000000000 00000 Buildings and Property
Walmark 04-Nov-2019 Buyout/LBO Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

STADA Arzneimittel Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 01-Jan-2013 000000000000000000 Completed
  • 00000 000000000000
0000000000 01-Jan-2010 000000000 0000 Completed
  • 00000 000000000000
0000000000 01-Jan-2008 000000000 00.000 Completed
  • 00000 000000000000
00000000 26-Feb-2004 000000000 00.000 Completed
  • 00000 000000000000
Helvepharm 01-Jan-2000 Merger/Acquisition Completed
  • 2 buyers
To view this company’s complete exits history, request access »

STADA Arzneimittel Subsidiaries (5)

Company Name Industry Location Founded
SCIOTEC Diagnostics Technologies Diagnostic Equipment Tulln, Austria 2004
00000-000000 Distributors (Healthcare) Leobendorf, Austria 0000
00000000 Pharmaceuticals Vršac, Serbia 0000
0000000000 Pharmaceuticals Etten-Leur, Netherlands 0000
00000000 000 0000 Pharmaceuticals Huddersfield, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

STADA Arzneimittel Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore STADA Arzneimittel‘s full profile, request access.

Request full access to PitchBook

STADA Arzneimittel Executive Team (12)

Name Title Board
Seat
Contact
Info
Peter Goldschmidt Chief Executive Officer & Chairman Executive Board
Miguel Fernandez Ph.D Chief Technical Officer
Felix von Berg Director, Business Development/ Merger and Acquisitions
Ines Unglaub Associate, Business Development/ Mergers and Acquisitions
Mark Keatley Chief Financial Officer

7 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

STADA Arzneimittel Board Members (14)

Name Representing Role Since Contact
Info
00000 0000 STADA Arzneimittel Board Member 000 0000
0000 00000000 STADA Arzneimittel Deputy Chairman 000 0000
00000 00000000000 STADA Arzneimittel Chief Executive Officer & Chairman Executive Board 000 0000
000 000000 STADA Arzneimittel Board Member 000 0000

10 Former Board Members

You’re viewing 4 of 14 board members. Get the full list »